Selaginella bryopteris Aqueous Extract Improves Stability and Function of Cryopreserved Human Mesenchymal Stem Cells by Singh A. et al.
Oxidative Medicine and Cellular Longevity 2017 vol.2017
Selaginella bryopteris Aqueous Extract Improves
Stability and Function of Cryopreserved Human
Mesenchymal Stem Cells
Singh A., Jha A., Bit A., Kiassov A., Rizvanov A., Ojha A., Bhoi P., Patra P., Kumar A., Bissoyi A.
Kazan Federal University, 420008, Kremlevskaya 18, Kazan, Russia
Abstract
© 2017  Abhishek  Kumar  Singh  et  al.  The  effective  long-term cryopreservation  of  human
mesenchymal  stem cells  (MSCs)  is  an essential  prerequisite step and represents a critical
approach  for  their  sustained  supply  in  basic  research,  regenerative  medicine,  and  tissue
engineering applications. Therefore, attempts have been made in the present investigation to
formulate a freezing solution consisting of a combination of Selaginella bryopteris water-soluble
extract with and without dimethyl sulfoxide (Me 2 SO) for the efficient long-term storage of
human umbilical cord blood- (hUCB-) derived MSCs. The cryopreservation experiment using the
formulated freezing solution was further performed with hUCB MSCs in a controlled rate freezer.
A significant increase in postthaw cell viability and cell attachment of MSCs was achieved with
freezing medium containing Selaginella bryopteris water extract along with 10% Me 2 SO as
compared to the freezing medium containing Me 2 SO (10% v/v)  alone.  Furthermore,  the
decreasing apoptotic  events  and reactive oxygen species production along with increasing
expression of heat shock proteins also confirmed the beneficial effect of Selaginella bryopteris
water extract. The beneficial effect of Selaginella bryopteris water extract was validated by its
ability  to render postpreservation high cell  viability.  In  conclusion,  the formulated freezing
solution has been demonstrated to be effective for the standardization of cryopreservation
protocol for hMSCs.
http://dx.doi.org/10.1155/2017/8530656
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